HARVARD BIOSCIENCE, INC. Payments for Restructuring
HARVARD BIOSCIENCE, INC. (HBIO) reported Payments for Restructuring of $258.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-13.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsForRestructuring · last filed 2026-03-13
- HARVARD BIOSCIENCE, INC. payments for restructuring for the quarter ending 2025-03-31 was $82.00K.
- HARVARD BIOSCIENCE, INC. payments for restructuring for the quarter ending 2024-12-31 was $241.00K.
- HARVARD BIOSCIENCE, INC. payments for restructuring for the quarter ending 2024-09-30 was $152.00K.
- HARVARD BIOSCIENCE, INC. payments for restructuring for the quarter ending 2022-12-31 was $177.00K, a 68.57% increase year-over-year.
- HARVARD BIOSCIENCE, INC. payments for restructuring for fiscal 2025 was $258.00K, a 68.19% decline from fiscal 2024.
- HARVARD BIOSCIENCE, INC. payments for restructuring for fiscal 2024 was $811.00K, a 1.25% increase from fiscal 2023.
- HARVARD BIOSCIENCE, INC. payments for restructuring for fiscal 2023 was $801.00K, a 179.09% increase from fiscal 2022.
- HARVARD BIOSCIENCE, INC. payments for restructuring for fiscal 2022 was $287.00K, a 81.08% decline from fiscal 2021.
| Period end | Payments for Restructuring 3 month | Payments for Restructuring 6 month | Payments for Restructuring 9 month | Payments for Restructuring 12 month |
|---|---|---|---|---|
| 2025-12-31 | $258.00K 10-K · filed 2026-03-13 | |||
| 2025-03-31 | $82.00K 10-Q · filed 2025-05-12 | $323.00K derived: sum of 2 quarters · filed 2026-03-13 | $475.00K derived: sum of 3 quarters · filed 2026-03-13 | |
| 2024-12-31 | $241.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | $393.00K derived: sum of 2 quarters · filed 2026-03-13 | $811.00K 10-K · filed 2026-03-13 | |
| 2024-09-30 | $152.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $570.00K 10-Q · filed 2024-11-08 | ||
| 2024-06-30 | $418.00K 10-Q · filed 2024-08-08 | |||
| 2023-12-31 | $801.00K 10-K · filed 2025-03-14 | |||
| 2022-12-31 | $177.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | $287.00K 10-K · filed 2024-03-07 | ||
| 2022-09-30 | $110.00K 10-Q · filed 2022-11-09 | |||
| 2021-12-31 | $105.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | $590.00K derived: sum of 2 quarters · filed 2023-03-09 | $1.24M derived: sum of 3 quarters · filed 2023-03-09 | $1.52M 10-K · filed 2023-03-09 |
| 2021-09-30 | $485.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05 | $1.14M derived: sum of 2 quarters · filed 2021-11-05 | $1.41M 10-Q · filed 2021-11-05 | $1.87M derived: sum of 4 quarters · filed 2022-03-11 |
| 2021-06-30 | $653.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | $927.00K 10-Q · filed 2021-08-06 | $1.39M derived: sum of 3 quarters · filed 2022-03-11 | |
| 2021-03-31 | $274.00K 10-Q · filed 2021-05-07 | $732.00K derived: sum of 2 quarters · filed 2022-03-11 | ||
| 2020-12-31 | $458.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | $1.95M 10-K · filed 2022-03-11 | ||
| 2020-09-30 | $1.49M 10-Q · filed 2020-11-06 | |||
| 2020-06-30 | $557.00K 10-Q · filed 2020-08-10 | $1.16M derived: sum of 2 quarters · filed 2020-08-10 | ||
| 2020-03-31 | $605.00K 10-Q · filed 2020-08-10 | |||
| 2019-12-31 | $281.00K 10-K/A · filed 2021-03-17 | |||
| 2019-09-30 | $1.00K 10-Q · filed 2019-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |